Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 20/20 | 0.82 |
| ▸ | PPARG | P37231 | 12/20 | 0.82 |
| ▸ | PPARD | Q03181 | 8/20 | 0.82 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.65 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.65 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.65 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.65 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.65 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5111743 | 0.94 | PPARA (0.89) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL5120237 | 0.94 | PPARA (0.82) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL5125251 | 0.92 | PPARA (0.79) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL5147335 | 0.90 | PPARA (1.00) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL29557298 | 0.90 | PPARA (1.00) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL2742676 | 0.90 | PPARA (1.00) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL5125451 | 0.90 | PPARA (0.75) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL5111622 | 0.90 | PPARA (0.82) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL5125922 | 0.89 | PPARA (0.75) | PPARAPPARGPPARDPSEN1PSEN2 | |
| SCHEMBL5119455 | 0.88 | PPARA (0.79) | PPARAPPARGPPARDPSEN1PSEN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7361783-B2 | (2S)-2-ethylphenylpropionic acid derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2008-04-22 | — | — | US | claimed |
| US-7361783-B2 | (2S)-2-ethylphenylpropionic acid derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2008-04-22 | — | — | US | disclosed |
| EP-1508566-B1 | (2S)-2-ETHYLPHENYLPROPIONIC ACID DERIVATIVE | KYORIN SEIYAKU KK (JP) | 2007-07-18 | — | — | EP | disclosed |
| US-20060084702-A1 | (2S)-2-ethylphenylpropionic acid derivative | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2006-04-20 | — | — | US | disclosed |
| EP-1508566-A1 | (2S)-2-ETHYLPHENYLPROPIONIC ACID DERIVATIVE | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 2005-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060084702-A1 | (2S)-2-ethylphenylpropionic acid derivative | PPARA, PPARG, PPARD | PPARA 1/4885PPARG 2/4885PPARD 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.